LaSalle Street Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

LaSalle Street Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$285K	Hold	5,611	–	–	0.33%	71
2019 Q2	$254K	Hold	5,611	–	–	0.3%	80
2019 Q1	$268K	Hold	5,611	–	–	0.32%	79
2018 Q4	$292K	Hold	5,611	–	–	0.42%	77
2018 Q3	$348K	Sell	5,611 -4,218	-43%	-$250K	0.41%	74
2018 Q2	$544K	Hold	9,829	–	–	0.54%	63
2018 Q1	$622K	Sell	9,829 -1,605	-14%	-$103K	0.49%	69
2017 Q4	$701K	Hold	11,434	–	–	0.48%	63
2017 Q3	$729K	Hold	11,434	–	–	0.54%	63
2017 Q2	$637K	Hold	11,434	–	–	0.52%	56
2017 Q1	$622K	Hold	11,434	–	–	0.52%	58
2016 Q4	$668K	Hold	11,434	–	–	0.59%	53
2016 Q3	$617K	Hold	11,434	–	–	0.57%	55
2016 Q2	$841K	Hold	11,434	–	–	0.8%	41
2016 Q1	$730K	Hold	11,434	–	–	0.72%	45
2015 Q4	$787K	Hold	11,434	–	–	0.78%	40
2015 Q3	$677K	Hold	11,434	–	–	0.72%	45
2015 Q2	$761K	Hold	11,434	–	–	0.74%	46
2015 Q1	$737K	Hold	11,434	–	–	0.72%	48
2014 Q4	$675K	Buy	+11,434	New	+$645K	0.66%	51

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LaSalle Street Capital Management's BMY Position: Q3 2019 in Review

LaSalle Street Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2019 at 5,611 shares worth $285K. The position accounts for 0.33% of the portfolio, ranked #71.

LaSalle Street Capital Management first reported a position in BMY in Q4 2014 and has held it in 20 quarters since. The position peaked at $841K in Q2 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

LaSalle Street Capital Management held 5,611 shares of Bristol-Myers Squibb worth $285K as of Q3 2019.
LaSalle Street Capital Management left its Bristol-Myers Squibb share count unchanged in Q3 2019.
Bristol-Myers Squibb made up 0.33% of LaSalle Street Capital Management's portfolio in Q3 2019, its #71 holding.
LaSalle Street Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 20 quarters since.
LaSalle Street Capital Management's Bristol-Myers Squibb position peaked at $841K in Q2 2016.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.